Lung cancer is a continuously evolving disease area. During the past year, many updates in lung cancer were seen. Prof. Amr Shafik (Professor of Clinical Oncology, Ain Shams University) has chosen 3 very interesting trials that have been presented in ESMO, NEJM & 2022 for us in this informative summary.